Despite extensive Chlamydia screening of asymptomatic young women in a variety of health care settings (Swedish Institute for Infectious Disease Control, 2005), the incidence of Chlamydia infections has continuously increased in Sweden since the mid-1990s. Since 1988, C. trachomatis, together with other sexually transmitted diseases (STDs), is regulated under Swedish law, which consists of contact tracing, mandatory partner notification, and compulsory testing of suspicious partners. Between 1988 and 1994, the prevalence of Chlamydia decreased by 62% in Sweden, a trend that, however, eventually gave way in 1995. After 1995, the prevalence of Chlamydia increased each year, reaching the same level in 2005 as in 1988. The decrease in Chlamydia, which was observed after 1988, took place at the same time that large campaigns for safer sex were in progress because of the risk of HIV. The changes in sexual behavior to fewer sexual partners that took place during this period were due to the acute awareness of HIV infection. When the fear of HIV diminished once it became obvious that there was no spread of HIV in the general population, as had been confirmed by the vigorous testing in Sweden (Christenson & Stillstrom, 1995), a reverse trend was observed. HIV was never introduced into the general population in Sweden. The spread of HIV has largely been restricted to three subpopulations: men who have sex with men, intravenous drug abusers, and heterosexuals from endemic areas. The heterosexual transmission in this group had occurred before its arrival in Sweden. This trend to safer sexual practice was observed in several countries in Western Europe during the same period and, as in Sweden, was interrupted in the mid1990s (Fenton & Lowndes, 2004). Genital infections that are caused by Chlamydia are the most common sexually transmitted infections in Sweden, as well as in the rest of the Western world (Low et al., 2006). Chlamydia is the only STD that affects the general population in Sweden. The Swedish strategy to combat Chlamydia is based on extensive screening of young women and partner intervention and all testing and treatment are free of charge. Evidence for the long-term effectiveness of Chlamydia screening programs are lacking (Gotz et al., 2005; Low & Egger, 2002). Regrettably, large-scale screening of asymptomatic women has not reduced the prevalence of Chlamydia in Sweden or in other Scandinavian countries (Hiltunen-Beck et al., 2003; Westh & Kolmos, 2003). Most screening programs for asymptomatic Chlamydia infections are based on the assumption that there is a high-risk of complications after an asymptomatic Chlamydia infection, a conception that has lately been questioned. Recent data indicate that there has been an overestimation of the risk for pelvic complications (Boeke, van Bergen, Morre, & van Everdingen, 2005; van Valkengoed et al., 2004) and that the natural course of asymptomatic Chlamydia infections is a high degree of clearance (Morre et al., 2002). In men, there are no conclusive studies showing that men infected with Chlamydia are less fertile than uninfected men (Kraus & Bohring, 2003). Overestimation and uncertainty of the incidence of complications will produce misleading results about the cost-effectiveness of the screening programs. To develop a more effective screening strategy, it is important to define persons at risk. Although the importance of targeting high-risk persons has been extensively discussed, the difficulty still lies in defining these groups. Persons with a prior notification for Chlamydia infection or patients attending S. Sylvan (&) B. Christenson Department of Communicable Disease Control and Prevention, Uppsala County Council, Smittskyddsenheten, Dag Hammarskjolds vag 17, 751 85 Uppsala, Sweden e-mail: staffan.sylvan@lul.se